☆ 4.7 Editorial Material

Multitarget disease-modifying therapy in Parkinson's disease?

LANCET NEUROLOGY (2015)

期刊

LANCET NEUROLOGY

卷 14, 期 10, 页码 975-976

出版社

ELSEVIER SCIENCE INC

DOI: 10.1016/S1474-4422(15)00227-6

关键词

-

类别

Clinical Neurology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Review Neurosciences

Mechanism of Mesenchymal Stem Cells as a Multitarget Disease-Modifying Therapy for Parkinson's Disease

Aziz Unnisa, Kamal Dua, Mohammad Amjad Kamal

Summary: Parkinson's disease is a prevalent neurodegenerative disorder that affects the basal nuclei and impairs motor and cognitive functions. The disease is characterized by a loss of dopaminergic neurons and the aggregation of Lewy bodies. Current medications only relieve symptoms and do not cure the disease, highlighting the need for therapies that can effectively stop or reverse degeneration. Cell-based therapies using mesenchymal stem cells (MSCs) have gained attention for their abundance in the body, proliferation ability, and immunomodulation, showing promise in repairing dopaminergic neurons in Parkinson's patients.

CURRENT NEUROPHARMACOLOGY (2023)

添加到收藏夹

Review Cell & Tissue Engineering

Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson's disease

Yi Zhuo, Xuan Li, Zhengwen He, Ming Lu

Summary: Parkinson's disease is a neurodegenerative disease characterized by the degeneration of dopaminergic neurons. Recent studies have shown that the activation of a neuroimmune response plays a key role in the development of the disease. Alpha-synuclein, the primary pathological marker of PD, can trigger a neuroinflammatory response and activate the dopaminergic neuron's neuroimmune response through antigen presentation. Further research on the neuroimmune response mechanism may open new methods for its prevention and therapy.

STEM CELL RESEARCH & THERAPY (2023)

添加到收藏夹

Article Behavioral Sciences

Targeting microglial NLRP3 in the SNc region as a promising disease-modifying therapy for Parkinson's disease

Chen Qiao, Tao Dang, Yan Zhou, Yuan-Zhang Zhou, Rong Zhao, Min Wang

Summary: This study highlights the detrimental role of microglial NLRP3 in the survival of DA neurons in the SNc region, providing a potential strategy for rescuing DA neurons in PD progression. Knockdown of microglial NLRP3 shows promise in attenuating PD pathologies, suggesting a new avenue for disease-modifying therapy targeting NLRP3.

BRAIN AND BEHAVIOR (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic Mechanisms

Jay S. S. Schneider

Summary: Parkinson's disease is a progressive neurodegenerative disorder impacting millions of patients worldwide. While there are treatments available for symptoms, there is no proven therapy to slow or halt disease progression. The failure of disease-modifying agents in clinical trials can be attributed to factors such as patient selection and trial design. Additionally, treatment choices have not adequately addressed the multiple and complex pathogenic mechanisms involved in Parkinson's disease. This paper suggests that using multi-functional therapeutics, such as GM1 ganglioside, which target multiple pathogenic mechanisms, may be a promising alternative strategy for success.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Review Chemistry, Medicinal

Multitarget therapeutic approaches for Alzheimer's and Parkinson's disease: an opportunity or an illusion?

Maria Joao Matos

Summary: Alzheimer's and Parkinson's disease are the most prevalent neurodegenerative diseases globally, with no cure currently available. There is an urgent need for multi-targeted therapeutic approaches to effectively manage these conditions.

FUTURE MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson's disease

Vasanti Suvarna, Kajal Deshmukh, Manikanta Murahari

Summary: Alpha-synuclein plays a key role in neurodegenerative diseases, especially Parkinson's disease. Recent advances in oligonucleotide chemistry have shown potential in targeting alpha-synuclein for therapeutic intervention in neurodegenerative diseases.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease

Tom Foltynie, Sonia Gandhi, Cristina Gonzalez-Robles, Marie-Louise Zeissler, Georgia Mills, Roger Barker, James Carpenter, Anette Schrag, Anthony Schapira, Oliver Bandmann, Stephen Mullin, Joy Duffen, Kevin McFarthing, Jeremy Chataway, Mahesh Parmar, Camille Carroll

Summary: Multi-arm, multi-stage platform designs have improved the efficiency of clinical trials in the field of oncology. Foltynie et al. discuss the challenges and considerations of using this approach to assess potential disease-modifying treatments in progressive neurological conditions such as Parkinson's disease.

BRAIN (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Gene-Based Therapeutics for Parkinson's Disease

Karim E. Shalaby, Omar M. A. El-Agnaf

Summary: Gene therapy has the potential to replace current treatments for Parkinson's disease and has been shown to be safe and effective in current trials.

BIOMEDICINES (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy

Yilong Xi, Yun Chen, Yi Jin, Guochen Han, Mingjie Song, Tingting Song, Yang Shi, Ling Tao, Zewei Huang, Jianping Zhou, Yang Ding, Huaqing Zhang

Summary: This article summarizes the complex pathogenesis of Alzheimer's disease (AD) and the interaction between different therapeutic targets. It discusses the key challenges in translating anti-AD nanomedicine from benchtop to bedside and highlights the recent advances in exploring pathogenesis-inspired nanomaterials in AD treatment.

JOURNAL OF CONTROLLED RELEASE (2022)

添加到收藏夹

Article Environmental Sciences

Gut-oriented disease modifying therapy for Parkinson's disease

Patrick D. O'Hara, Norma Serra-Sogas, Lauren McWhinnie, Kim Pearce, Nicole Le Baron, Gregory O'Hagan, Andrea Nesdoly, Tunai Marques, Rosaline Canessa

Summary: An increasing number of marine conservation initiatives rely on data from AIS to inform impact assessments and mitigation policies. However, AIS does not capture a considerable proportion of vessel traffic in many regions. This study introduces two complementary techniques using optical imagery to collect traffic data in the Canadian Salish Sea, revealing significant non-AIS traffic patterns. Overall, the study's findings highlight the importance of incorporating non-AIS data for a more comprehensive understanding of vessel traffic. Evaluation: 8 out of 10.

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Bilirubin: A Promising Therapy for Parkinson's Disease

Sri Jayanti, Rita Moretti, Claudio Tiribelli, Silvia Gazzin

Summary: With the increase in life expectancy, the prevalence of Parkinson's disease is expected to rise, but the diagnosis still relies on clinical symptoms. Current treatments mainly focus on alleviating symptoms without stopping or slowing down disease progression. Therefore, exploring the therapeutic potential of bilirubin in PD is crucial for the development of disease-modifying treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Promising tacrine/huperzine A-based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget

Shinghung Mak, Wenming Li, Hongjun Fu, Jialie Luo, Wei Cui, Shengquan Hu, Yuanping Pang, Paul R. Carlier, Karl Wahkeung Tsim, Rongbiao Pi, Yifan Han

Summary: Neurodegenerative disorders like Alzheimer's and Parkinson's diseases are devastating in the elderly population, with current treatments only able to alleviate symptoms. Collaborative research has led to the development of dimeric acetylcholinesterase inhibitors that may have disease-modifying effects through multiple pathways.

JOURNAL OF NEUROCHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

A Chiral Nanocomplex for Multitarget Therapy to Alleviate Neuropathology and Rescue Alzheimer's Cognitive Deficits

Huarong Tan, Yuqi Huang, Shuqing Dong, Zetai Bai, Cheng Chen, Xiunan Wu, Minghao Chao, Hanrong Yan, Shaoshen Wang, Deqin Geng, Fenglei Gao

Summary: This article reports the development of a stimulus-responsive chiral nanomaterial, MSP-U, for the treatment of Alzheimer's disease. MSP-U stimulates neural stem cell differentiation, promotes in situ hydrogen production, and clears beta-amyloid plaques, showing promising potential as a treatment for AD using chiral nanomaterials.

SMALL (2023)

添加到收藏夹

Article Chemistry, Medicinal

From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects

Caterina Pont, Tiziana Ginex, Christian Grinan-Ferre, Matthias Scheiner, Alexia Mattellone, Noemi Martinez, Elsa M. Arce, Yolanda Soriano-Fernandez, Marina Naldi, Angela De Simone, Marta Barenys, Jesus Gomez-Catalan, Belen Perez, Raimon Sabate, Vincenza Andrisano, Maria Isabel Loza, Jose Brea, Manuela Bartolini, Maria Laura Bolognesi, Michael Decker, Merce Pallas, F. Javier Luque, Diego Munoz-Torrero

Summary: Through virtual screening, a lead compound with potential anti-AD activity has been identified, showing activity against BACE-1 and cholinesterases, while also playing a role in inhibiting Ab42 and tau aggregation, improving memory, and increasing synaptic protein levels.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Review Cell Biology

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities

Jannik Prasuhn, Ryan L. Davis, Kishore R. Kumar

Summary: Parkinson's disease is complicated and mitochondrial dysfunction plays a key role in its pathophysiology. While there are still gaps in knowledge, targeting various aspects of mitochondrial function and using combined therapeutic approaches may offer the best chance for developing effective novel therapies.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Letter Clinical Neurology

Levetiracetam-responsive belly dancer's syndrome in a case of progressive supranuclear palsy

Pasquale Nigro, Michele Romoli, Federico Paolini Paoletti, Simone Simoni, Paolo Calabresi, Nicola Tambasco

ACTA NEUROLOGICA BELGICA (2021)

添加到收藏夹

Review Clinical Neurology

Reperfusion strategies in stroke due to isolated cervical internal carotid artery occlusion: systematic review and treatment comparison

Michele Romoli, Maria Giulia Mosconi, Patrizia Pierini, Andrea Alberti, Michele Venti, Valeria Caso, Simone Vidale, Enrico Maria Lotti, Marco Longoni, Paolo Calabresi, Georgios Tsivgoulis, Maurizio Paciaroni

Summary: In acute ischemic stroke associated with isolated cervical ICA occlusion, bridging (IVT + EVT) may lead to a higher rate of functional independence at follow-up without increasing mortality. The low quality of available studies prevents firm conclusions, necessitating randomized-controlled clinical trials to define optimal treatment in this AIS subgroup.

NEUROLOGICAL SCIENCES (2021)

添加到收藏夹

Article Clinical Neurology

Changes of olfactory tract in Parkinson's disease: a DTI tractography study

Pasquale Nigro, Andrea Chiappiniello, Simone Simoni, Federico Paolini Paoletti, Giulia Cappelletti, Pietro Chiarini, Marta Filidei, Paolo Eusebi, Giorgio Guercini, Valerio Santangelo, Roberto Tarducci, Paolo Calabresi, Lucilla Parnetti, Nicola Tambasco

Summary: This study utilized diffusion tensor imaging to analyze the olfactory tract in Parkinson's disease patients, revealing significant decreases in fractional anisotropy and tract volume in the Parkinson's disease group compared to controls. These findings help characterize hyposmia in Parkinson's disease.

NEURORADIOLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Giacomo Balla: A Painter in the Context of Neuroscience

Letizia Maria Cupini, Paolo Calabresi

Summary: Giacomo Balla, an Italian Futurist painter, had a profound interest in neurophysiological and neurological sciences, which greatly influenced his personal painting style. His famous artworks serve as historical records of the neuroscience environment at the turn of the 20th century.

NEUROSCIENTIST (2022)

添加到收藏夹

Article Clinical Neurology

CACNA1A-p.Thr501Met mutation associated with familial hemiplegic migraine: a family report

Marina Romozzi, Guido Primiano, Eleonora Rollo, Lorena Travaglini, Paolo Calabresi, Serenella Servidei, Catello Vollono

Summary: Hemiplegic migraine is a rare form of migraine that can be sporadic or familial. A mutation in the CACNA1A gene, specifically the p.Thr501Met variant, was found in 12 out of 15 patients in a family, leading to familial hemiplegic migraine. The mutation can prevalently occur as hemiplegic migraine without significant cerebellar involvement.

JOURNAL OF HEADACHE AND PAIN (2021)

添加到收藏夹

Article Clinical Neurology

Transcranial Magnetic Stimulation Exerts Rejuvenation Effects on Corticostriatal Synapses after Partial Dopamine Depletion

Giuseppina Natale, Annabella Pignataro, Gioia Marino, Federica Campanelli, Valeria Calabrese, Antonella Cardinale, Silvia Pelucchi, Elena Marcello, Fabrizio Gardoni, Maria Teresa Viscomi, Barbara Picconi, Martine Ammassari-Teule, Paolo Calabresi, Veronica Ghiglieri

Summary: This study suggests that acute iTBS treatment can alleviate corticostriatal dysfunctions in a rat model of early parkinsonism by modulating NMDAR-dependent plasticity, leading to structural changes and striatal compensatory adaptation.

MOVEMENT DISORDERS (2021)

添加到收藏夹

Article Clinical Neurology

Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia

Valentina Damato, Claudia Papi, Gregorio Spagni, Amelia Evoli, Gabriella Silvestri, Gianvito Masi, Eleonora Sabatelli, Lucia Campetella, Andrew McKeon, Francesca Andreetta, Vittorio Riso, Gabriele Monte, Marco Luigetti, Guido Primiano, Paolo Calabresi, Raffaele Iorio

Summary: The study evaluated the long-term outcomes of patients with autoimmune cerebellar ataxia, distinguishing between paraneoplastic and non paraneoplastic cases. Neural autoantibodies were detected in a significant portion of patients, with all patients receiving immunotherapy. Patients with paraneoplastic cerebellar syndrome had higher SARA scores compared to idiopathic ACA patients, and those with good outcomes had lower SARA scores.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Remission of functional motor symptoms following esketamine administration in a patient with treatment-resistant depression: a single-case report

Lorenzo Moccia, Pierluigi Lanzotti, Maria Pepe, Laura Palumbo, Delfina Janiri, Giovanni Camardese, Anna Rita Bentivoglio, Marco Di Nicola, Paolo Calabresi, Gabriele Sani

Summary: Functional movement disorders (FMD) are abnormal involuntary movements not consistent with neurological diseases. They often co-occur with mood and anxiety disorders and have poor clinical outcomes. This case report presents the successful treatment of FMD symptoms in a patient with treatment-resistant depression (TRD) using esketamine.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2022)

添加到收藏夹

Meeting Abstract Clinical Neurology

Cognitive decline in late-onset epilepsy of undefined etiology: A longitudinal cohort study

Michele Romoli, Elena Nardi Cesarini, Claudio Liguori, Lucia Farotti, Paolo Eusebi, Carmen Calvello, Andrea Romigi, Nicola Mercuri, Lucilla Parnetti, Paolo Calabresi, Cinzia Costa

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

添加到收藏夹

Meeting Abstract Clinical Neurology

Lexical-semantic system disruption correlation with Alzheimer's pathophysiological processes

Emanuele Maria Costantini, Guido Maria Giuffre, Salvatore Citro, Davide Quaranta, Antonio Daniele, Paolo Calabresi, Camillo Marra

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

添加到收藏夹

Meeting Abstract Clinical Neurology

Theory of mind: A clue to functional movement disorders diagnosis

Sonia Di Tella, Maria Caterina Silveri, Rita Lo Monaco, Martina Petracca, Tondinelli Alice, Antonucci Gabriella, Gino Pozzi, Giulia Di Lazzaro, Paolo Calabresi, Anna Rita Bentivoglio

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

添加到收藏夹

Meeting Abstract Clinical Neurology

Cognitive decline risk stratification in people with late-onset epilepsy of unknown etiology: An electroencephalographic connectivity and graph theory pilot study

Cinzia Costa, Fabrizio Vecchio, Michele Romoli, Francesca Miraglia, Elena Nardi Cesarini, Francesca Alu, Paolo Calabresi, Paolo Maria Rossini

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

添加到收藏夹

Article Clinical Neurology

Mechanical thrombectomy in acute ischemic stroke due to large vessel occlusion in the anterior circulation and low baseline National Institute of Health Stroke Scale score: a multicenter retrospective matched analysis

Andrea Maria Alexandre, Iacopo Valente, Alessandro Pedicelli, Angelo Maria Pezzullo, Francesca Colo, Luca Scarcia, Andrea Romi, Mariangela Piano, Antonio Macera, Joseph Domenico Gabrieli, Giacomo Cester, Antonio Armando Caragliano, Sergio Lucio Vinci, Maria Ruggiero, Christian Commodaro, Andrea Saletti, Guido Andrea Lazzarotti, Mirco Cosottini, Valerio Da Ros, Luigi Bellini, Emilio Lozupone, Adriana Paladini, Valerio Brunetti, Roberta Morosetti, Giovanni Frisullo, Paolo Calabresi, Giacomo Della Marca, Aldobrando Broccolini

Summary: This study evaluated the effectiveness of mechanical thrombectomy in patients with acute ischemic stroke due to large vessel occlusion and baseline mild neurological symptoms. After propensity score matching, patients who received immediate mechanical thrombectomy had a higher chance of excellent outcome at 90 days compared to those who received best medical management/rescue mechanical thrombectomy, with a similar risk of death.

NEUROLOGICAL SCIENCES (2022)

添加到收藏夹

Meeting Abstract Clinical Neurology

Management and treatment of refractory status epilepticus: A retrospective cohort study

Eleonora Rollo, Fedele Dono, Daniela Bernardo, Serenella Servidei, Paolo Calabresi, Catello Vollono

EPILEPSIA (2021)

添加到收藏夹

Article Neurosciences

Mechanical thrombectomy in patients with stroke due to large vessel occlusion in the anterior circulation and low scale score

Andrea M. Alexandre, Lacopo Valente, Giovanni Frisullo, Roberta Morosetti, Danilo Genovese, Andrea Bartolo, Riccardo Gigli, Claudia Rollo, Luca Scarcia, Francesca Carosi, Giusy Fortunato, Francesco D'Argento, Paolo Calabresi, Giacomo Della Marca, Alessandro Pedicelli, Aldobrando Broccolini

Summary: The study found that mechanical thrombectomy may have potential benefits in patients with acute ischemic stroke due to large vessel occlusion and low National Institute of Health stroke scale score at presentation. Additionally, these patients may benefit from a prolonged time window for treatment.

JOURNAL OF INTEGRATIVE NEUROSCIENCE (2021)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.